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A B S T R A C T
Four new iridoids (1–4), together with three known iridoids (5–7), one known ﬂavonoid glycoside, three phe-
nolic acids and one phytosterol were isolated from the roots of Valeriana dioscoridis. Their structures were
elucidated by means of NMR spectroscopy and mass spectrometry. This is the ﬁrst report on the phytochemical
composition of the non-volatile constituents of V. dioscoridis and the occurrence of a bis-iridoid glycoside in the
genus Valeriana. The antiproliferative eﬀects of the iridoids (1–7) were evaluated against three human cancer
cell lines of gynacological origin (HeLa, A2780 and T47D) at 10, 30 and 60 μM concentrations, using the MTT
assay and they elicited modest antiproliferative activity when compared to the reference agent, cisplatin.
1. Introduction
The genus Valeriana (formerly Valerianaceae, now Caprifoliaceae)
contains around 200 species distributed worldwide [1]. It is represented
by 12 species in the ﬂora of Turkey including V. dioscoridis [2]. Among
Valeriana species, the oﬃcial one V. oﬃcinalis, and V. jatamansi have
long been used as a sedative, anxiolytic and sleep inducing activities
since remote times [3,4]. The extracts of some Valeriana species as well
as the isolates were shown to exhibit a variety of bioactivities including
anxiolytic, anticonvulsant, neuroprotective and cytotoxic activities
[1,3–6]. Previous phytochemical studies on some Valeriana species re-
vealed the presence of iridoids, sesquiterpenes, lignans and essential
oils [4,7–9]. Iridoids obtained from several Valeriana species exhibited
notable cytotoxic and antitumor activities in both in vitro and in vivo
assays [7,8,10]. Previously, V. dioscoridis was only investigated for the
volatile principles in terms of its secondary metabolite composition
[11]. As a part of our ongoing eﬀorts to search for new bioactive
compounds from Turkish medicinal plants, we investigated the sec-
ondary metabolites of the roots of V. dioscoridis. Herein, the isolation
and structure elucidation of four new iridoids, dioscorin A (1), 1-epi-
bosnarol (2), dioscorin B (3) and C (4) and three known analogues
(5–7) as well as their in vitro antiproliferative activities are reported.
2. Experimental
2.1. General
Optical rotations ([a]D27) were measured by using a Perkin-Elmer
341 polarimeter. UV and IR spectra were recorded on a HP Agilent
8453 spectrophotometer and a Perkin-Elmer 2000 FT-IR spectrometer,
respectively. NMR spectra were recorded in CD3OD and CDCl3 on a
Bruker Avance DRX 500 spectrometer at 500MHz for 1H and 125MHz
for 13C. The signals of the deuterated solvents were taken as references.
The chemical shift values (δ) were given in ppm and coupling constants
(J) are in Hz. HRESIMS data were recorded on a Thermo Scientiﬁc Q-
Exactive Plus Orbitrap mass spectrometer equipped with ESI ion source
in positive ionization mode. Fractions were monitored by TLC analyses
on silica gel 60 F254 precoated plates (Merck), and spots were visua-
lized under UV light (254/366 nm) or by spraying with 1% vanillin/
H2SO4 followed by heating. For medium-pressure liquid chromato-
graphic (MPLC) separations, the Sepacore® Flash Systems X10/X50
(Büchi) system was used with Redi sep columns (LiChroprep C18: 130,
43 and 30 g; SiO2: 120, 40 and 12 g, Teledyne Isco). Sephadex LH-20
(Fluka) was used for gel ﬁltration chromatography. All the solvent used
were of analytical grade.
2.2. Plant material
The roots of Valeriana dioscoridis Sm. were collected from Osmaneli,
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Bilecik, Turkey, in May 2016. The plant material was identiﬁed by one
of us (HK) and a voucher specimen (YEF 16001) has been deposited at
the Herbarium of the Department of Pharmacognosy, Faculty of
Pharmacy, Yeditepe University, İstanbul, Turkey.
2.3. Extraction and isolation
The air-dried and powdered roots of V. dioscoridis (155 g) were ex-
tracted with MeOH (1550mL) at 40 °C for 2× 4 h. The combined ex-
tracts were evaporated under reduced pressure to yield a crude extract
(38 g, yield 24.5%), which was suspended in H2O (120mL) and then
partitioned against n-hexane (3× 120mL), CHCl3 (3×120mL), EtOAc
(3× 120mL) and n-buOH (3×120mL) respectively. The n-hexane
subextract was separated by SiO2-MPLC (120 g) eluting with stepwise n-
hexane-EtOAc gradient (0 to 70% EtOAc) to give β-sitosterol (160mg).
The CHCl3 subextract (1.3 g) was similarly subjected to SiO2-MPLC
(120 g) eluting with stepwise n-hexane-EtOAc gradient (0 to 80%
EtOAc) to yield 8-epi-deoxyloganin aglycone (5, 4 mg) and 1-epi-bos-
narol (2, 17mg). The EtOAc subextract (9.97 g) was loaded onto a
Sephadex LH-20 gel (100 g) using MeOH as the mobile phase to obtain
hesperidin (55mg) along with three main fractions, frs. A-C. Fr. A was
subjected to C18-MPLC (130 g) eluting with H2O/MeOH gradient (0 to
70% MeOH) to obtain frs. A1–5. Puriﬁcation of A1 (61mg) by Sephadex
LH-20 (12 g, MeOH) CC, followed by SiO2-MPLC (12 g) eluting with
CH2Cl2-MeOH mixtures (95:5 to 80:20) yielded dioscoridin A (1, 3 mg).
Fr. A4 (246mg) was submitted to SiO2-MPLC (40 g) using the gradient
mixture of CH2Cl2-MeOH (100:0 to 70:30) as mobile phase to aﬀord
10,2′-diacetylpatrinoside (7, 10mg), 10-acetylpatrinoside (6, 4 mg) and
dioscoridin B (3, 44mg). Fr. A5 (55mg) was applied to SiO2-MPLC
(12 g) using CH2Cl2-MeOH mixtures (100:0 to 85:15) to give dioscor-
idin C (4, 12mg). Fr. B was subjected to C18-MPLC (43 g) eluting with
stepwise H2O/MeOH gradient (100:0 to 30:70) to obtain caﬀeic acid
(52mg) together with a fraction (40mg) containing impure chlorogenic
acid, which was submitted to further puriﬁcation by SiO2-MPLC (12 g)
using a gradient solvent system of CH2Cl2-MeOH mixtures (100:0 to
70:30) to give chlorogenic acid (9mg). Fr. C (151mg) was separated by
C18-MPLC (30 g) eluting with stepwise H2O/MeOH gradient (90:10 to
40:60) to obtain 4,5-dicaﬀeoylquinic acid (3mg).
2.3.1. Dioscoridin A (1)
Amorphous powder; [a]D27=+8.0 (c=0.1, MeOH); UV
(MeOH):νmax= 208 nm; IR (KBr): νmax= 3374, 2925, 1616, 1508,
1455, 1282 cm−1; For 1H and 13C NMR data, see Table 1; HRESIMS m/z
225.1095 [M+Na]+ (calcd. For C10H18O4Na, 225.1103).
2.3.2. 1-epi-bosnarol (2)
Colorless oil; [a]D28=−18 (c=0.2, CHCl3); UV
(MeOH):νmax= 253 nm; IR (KBr): νmax= 3300, 2916, 1714, 1658,
1615, 1156 cm−1; For 1H and 13C NMR data, see Table 1; HRESIMS m/z
183.1019 [M+H]+ (calcd. For C10H15O3, 183.1021).
2.3.3. Dioscoridin B (3)
Amorphous powder; [a]D27=−41 (c=0.2, MeOH); UV
(MeOH):νmax= 205 nm; IR (KBr): νmax= 3399, 2961, 1740, 1372,
1251, 1074 cm−1; For 1H and 13C NMR data, see Table 2; HRESIMS m/z
731.2734 [M+Na]+ (calcd. For C31H48O18Na, 731.2738).
2.3.4. Dioscoridin C (4)
Amorphous powder; [a]D27=−79 (c=0.2, MeOH); UV
Table 1
13C (125MHz) and 1H (500MHz) NMR data of 1 (in CD3OD) and 2 (in CDCl3).
1 2
Position δC(ppm) δH(ppm), J (Hz) δC(ppm) δH(ppm), J (Hz)
1 64.5 3.46 dd (10.5, 6.0) 96.9 5.08 d (6.1)
3.21 dd (10.5, 8.4)
3 67.1 4.06 d (14.0) 161.8 7.17 s
4.01 d (14.0)
4 149.9 – 123.5 –
5 41.8 3.07m 32.3 2.89m
6 40.0 1.92 dd (12.9, 4.1) 31.6 1.30m (α)
1.72 dd (12.9, 6.0) 2.27m (β)
7 73.5 4.36 t (4.2) 33.3 1.87m (α)
1.22m (β)
8 52.6 1.97m 35.6 1.96m
9 44.9 2.09m 49.0 1.69m
10 63.3 3.79 dd (10.5, 6.6) 20.8 1.09 d (6.7)
3.67 dd (10.5, 6.9)
11 109.9 5.16 s 191.3 9.24 s
4.88 s
Assignments are based on COSY, HSQC, HMBC and NOESY experiments.
Table 2
13C (125MHz) and 1H NMR (500MHz) data of 3 and 4 in CD3OD.
3 4
Position δC(ppm) δH(ppm), J (Hz) Position δC(ppm) δH(ppm), J (Hz)
Unit “a”
1 93.3 5.92 d (5.1) 1 97.8 5.23 d (5.6)
3 140.2 6.32 s 3 153.3 7.49 s
4 116.0 – 4 112.7 –
5 33.9 2.92m 5 35.2 2.90m
6 40.7 2.00m 6 33.3 2.20a
1.81m 1.41a
7 72.3 4.25m 7 34.2 1.88a
8 46.1 2.08m 1.20a
9 43.3 2.16m 8 36.5 1.97m





10 20.7 1.09 d (6.2)
11 69.7 4.21 d (12.2) 11 168.5 –
4.05 d (12.2) 1′ 100.2 4.67 d (8.0)
10-COCH3 172.9 – 2′ 74.7 3.20 dd (8.9,
8.0)
10-COCH3 20.9 2.05 s 3′ 78.0 3.36 t (8.9)
1′ 173.3 – 4′ 71.5 3.28a
2′ 44.1 2.25 d (6.9) 5′ 78.4 3.31a
3′ 26.8 2.07a 6′ 62.7 3.89 dd (12.0,
1.4)
4′/5′ 22.6 0.97 d (6.4) 3.65 dd (12.0,
6.3)
1″ 100.9 4.50 d (8.0) Unit “b”
2″ 74.8 4.78 t (8.8) 1 97.8 5.25 d (5.6)
3″ 74.5 3.68a 3 152.5 7.41 s
4″ 80.2 3.65a 4 112.9 –
5″ 76.6 3.44m 5 35.2 2.90m






2″-COCH3 171.7 – 7 34.2 1.88a
2″-COCH3 21.1 2.09 s 1.20a
1′′′ 104.5 4.42 d (7.9) 8 36.5 1.97m
2′′′ 74.9 3.21 t (8.8) 9 49.2 1.75m
3′′′ 77.8 3.36 t (8.8) 10 20.7 1.09 d (6.2)
4′′′ 71.4 3.26 t (9.1) 11 169.6 –
5′′′ 78.2 3.33m COOCH3 51.6 3.69 s
6′′′ 62.5 3.87 dd (11.9,
1.9)
1′ 100.1 4.72 d (8.0)
3.62 dd (11.9,
6.1)
2′ 74.9 3.28 dd (9.0,
8.0)
3′ 75.6 3.61 t (9.0)
4′ 71.9 4.78 t (9.3)
5′ 76.5 3.50m




Assignments are based on COSY, HSQC, HMBC and NOESY experiments.
a Overlapped signals.
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(MeOH):νmax= 237 nm; IR (KBr): νmax= 3382, 2955, 1702, 1634,
1280, 1074 cm−1; For 1H and 13C NMR data, see Table 2; HRESIMS m/z
225.1095 [M+Na]+ (calcd. For C10H18O4Na, 225.1103).
2.4. Antiproliferative assay
Antiproliferative eﬀect of the isolated iridoids (1–7) were evaluated
in vitro on a panel of human gynaecological cancer cell lines (HeLa,
A2780, and T47D; isolated from cervical, ovarian and breast cancers,
respectively) using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylte-
trazolium bromide (MTT) colorimetric assay [12]. All cell lines were
purchased from European Collection of Cell Cultures (Salisbury, UK)
and maintained in Minimum Essential Medium (MEM) supplemented
with 10% fetal calf serum (FCS), 1% non-essential amino acids, and 1%
penicillin-streptomycin at 37 °C in humidiﬁed atmosphere containing
5% CO2. All media and supplements for these experiments were ob-
tained from Lonza Group Ltd. (Basel, Switzerland). Brieﬂy, cells were
seeded into 96-well plates (5000 cells/well) and incubated with three
concentrations of the compounds (10, 30 and 60 μM) for 72 h. After
that, 5 mg/mL MTT solution was added and the plates were incubated
for another 4 h. The formazan crystals were dissolved in dimethyl
sulfoxide and the absorbance was determined by a microplate reader, at
545 nm. Wells containing untreated cells were utilized as control. Two
independent experiments were carried out with ﬁve wells for each
condition. Cisplatin (Ebewe GmbH, Unterach, Austria), a clinically used
anticancer agent, was used as a reference agent.
3. Results and discussion
The roots of V. dioscoridis were extracted with MeOH. The crude
MeOH extract was dispersed in H2O and partitioned against n-hexane,
CHCl3, EtOAc and n-buOH respectively. Chromatographic separations
of the EtOAc, n-hexane and CHCl3 subextracts resulted in the isolation
of seven iridoids including four new ones (1–4) (Fig. 1), one ﬂavonoid
glycoside, three phenolic acids and one phytosterol.
Compound 1 was isolated as a colorless solid with a molecular
formula of C10H18O4, deduced from its HRESIMS (m/z 225.1095
[M+Na]+, calcd for C10H18O4Na, 225.1103). Analysis of the 1H and
13C NMR spectroscopic data (Table 1) indicated signals for one exo-
cyclic methylene [δH 5.16 and 4.88 (each s, H2–11), δC 149.9 (C-4) and
109.9 (C-11)], three hydroxymethylenes [δH 4.06 and 4.01 (each d,
J=14.0 Hz), δC 67.1 (C-3); δH 3.79 (dd, J=10.5, 6.6) and 3.67 (dd,
J=10.5, 6.9 Hz) H2–10, δC 63.3 (C-10); δH 3.46 (dd, J=10.5, 6.0 Hz)
and 3.21 (dd, J=10.5, 8.4 Hz), δC 64.5 (C-1)], one methylene [δH 1.92
(dd, J=12.9, 4.1 Hz) and 1.72 (dd, J=12.9, 6.0 Hz), δC 40.0 (C-6)],
one oxymethine [δH 4.36 (t, J=4.2 Hz), δC 73.5 (C-7)], and three
methines [δH 3.07, 2.09 and 1.97, each m, δC 41.8 (C-5), 44.9 (C-9) and
52.6 (C-8)]. Inspection of the COSY spectrum showed one spin system
involving H2–1, H-9, H-8, H2–10, H-7, H2–6 and H-5 (Fig. 2). These
ﬁndings were characteristic for a cyclopentanoid monoterpenic struc-
ture, an iridoid whose pyran ring is opened [7]. The absence of a long-
range coupling between C-3 and H2–1 or vice versa in the HMBC spec-
trum also supported this assumption. The location of the exocyclic
methylene group was established by the key cross-peaks between C-11
and H2–3/H-5 in the HMBC spectrum (Fig. 2). Further, one of the
hyroxymethylene groups was located at C-8 by the long-range cou-
plings from C-7 to H2–10 and C-9 to H2–10. The relative conﬁguration
of 1 was deduced as depicted by NOESY correlations of δH 3.07 (H-5)
with 2.09 (H-9); H-9 with 3.79 and 3.67 (H2−10); 4.36 (H-7) with 1.97
(H-8) and 1.72 (H-6α). To the best of our knowledge 1 is being reported
for the ﬁrst time and named as dioscoridin A.
Compound 2 was obtained as amorphous colorless oil. The mole-
cular formula, C10H14O3, was deduced from the quasimolecular ion
peak at m/z 183.1019 ([M+H]+ calcd 183.1021 for C10H15O3) in the
HRESIMS with an unsaturation of four. Its UV spectrum (253 nm) was
characteristic for C-4 substituted iridoids with a carbonyl containing
group. IR spectrum showed absorption bands due to hydroxyl
(3300 cm−1), aldehyde carbonyl (1714 cm−1) and oleﬁnic
(1658 cm−1) functionalities. The 1H NMR spectrum of 1 (Table 1)
displayed one aldehyde (δH 9.24 s), one oleﬁnic (δH 7.17 s), one
hemiacetal methine (δH 5.08 d, J=6.1 Hz), three methines (δH 2.89m,
1.96m and 1.69m), two non-equivalent methylenes (δH 2.27/1.30 and
1.87/1.22 each m) and a methyl (δH 1.09 d, J=6.7 Hz). The 13C-JMOD
NMR spectrum (Table 1) showed 10 signals which were characteristic
for a C10 iridoid skeleton with an aldehyde group (δC 191.3) [13]. A
detailed analysis of 2D NMR (COSY, HSQC and HMBC) spectra sug-
gested that the NMR ﬁndings closely resembled to those of bosnarol
[14,15]. However, C-9 and C-10 signals of 2 were observed to be shifted
to downﬁeld 4.9 and 4.4 ppm respectively when compared to those of
bosnarol. Furthermore, H-1 was also found to be slightly shifted
downﬁeld when compared to that of bosnarol [15]. These diﬀerences
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Fig. 1. Chemical structures of compounds 1–7 isolated from V. dioscoridis.
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at C-8. The relative conﬁguration of 2 was determined by NOESY ex-
periment. NOESY correlations of H-1/H-8, H-1/H-9, H-5/H-9, H-5/H-
6β as well as the absence of NOE correlation between H-9 and H3–10
indicated an α-conﬁguration for both OH and CH3 groups. These ﬁnd-
ings revealed that 2 is the C-1 epimer of bosnarol. The α-orientation of
the OH group at C-1 was also supported by comparison of the coupling
constant of H-1 (J=6.1 Hz) as well as the NMR data for structurally
very close two C-1 epimeric iridoids, artselaenins A and B [16]. Thus, 2
was named as 1-epi-bosnarol.
Compound 3 was isolated as an amorphous powder. Its HRESIMS
data (m/z 731.2734 [M+Na]+, calcd for C31H48O18Na, 731.2738)
supported a molecular formula of C31H48O18. The IR spectrum in-
dicated the presence of hydroxyl (3399 cm−1), ester carbonyl
(1740 cm−1) and oleﬁnic (1664 cm−1) functionalities. 1H NMR spec-
trum (Table 2) contained signals arising from an oleﬁnic (δH 6.32 s),
one hemiacetal (δH 5.92 d, J=5.1 Hz), two oxymethylenes [δH 4.27
(dd, J=10.8, 3.3), 4.21 (dd, J=10.8, 6.7 Hz); δH 4.21 and 4.05 (each
d, J=12.2 Hz), one oxymethine (δH 4.25m), two methines (δH 2.92m
and 2. 16m) as well as one non-equivalent methylene [δH 2.00m and
1.81m) signals. Furthermore, the spectrum also displayed signals due
to two acetyl methyls (δH 2.09 and 2.05), two anomeric proton re-
sonances [δH 4.50 (d, J=8.0 Hz) and 4.42 (d, J=7.9 Hz)] together
with the signals of a isovaleroyl unit [one methylene at δH 2.25 (d,
J=6.9), one methine at δH 2.07 and two equivalent methyl signals at
δH 0.97 (d, J=6.4 Hz)]. The 13C-JMOD NMR spectrum (Table 2)
showed 31 signals, 12 of which were assigned to two β-glucopyranose
units, ﬁve were ascribed to an isovaleroyl unit, and four were due to
two acetyl units. The remaining ten signals were consistent with a C10
iridoid aglycone. A detailed analysis of NMR data supported by 2D
experiments (COSY, HSQC and HMBC) suggested that the aglycone is
10-O-acetylpatrinoside-aglycone [17] and the sugar portion consists of
two glucopyranose units linked each other via a β-(1→4) bond. The
sites of attachment of the disaccharidic chain on the iridoid aglycone
was established by key cross-peak between δC 69.7 (C-11) and the
anomeric proton signal at δH 4.50 (H-1″) in the HMBC spectrum
(Fig. 2). The downﬁeld shifts for the H-1 (δH 5.92), H2–10 (δH=4.90
and 4.83) and the H-2″ (δH 4.78) indicated the sites of acylations. The
exact locations of acetyl and the isovaleroyl units were unambiguously
identiﬁed by HMBC spectrum. The acetyl carbonyl at δC 172.9 showed
long range correlation with H2–10 (δH 4.27 and 4.21) while the other
acetyl carbonyl at δC 171.7 coupled with H-2″ (δH 4.78) of inner glu-
copyranose in the HMBC spectrum. Similarly, a long range correlation
was observed between the carbonyl carbon of isovaleroyl moiety at δC
173.3 and H-1 (δH 5.92) of the aglycone which placed isovaleroyl at C-
1(OH). The relative conﬁgurations of C-1, C-5, C-7, C-8, and C-9 of the
aglycone were determined based on the NOESY spectrum. The NOE
correlations between H-1 and H-8, between H-8 and H-7 supported the
α orientations of H-1, H-7 and H-8. The coupling constant J1–9= 5.1 Hz
was consistent with H-1α and H-9β orientation [17]. Further NOE
correlations were observed between H-5 and H-9 and between H-9 and
H2–10 conﬁrming the β orientations of H-5 and H-9. Another key data
was the absence of NOE between H-9 and H-7 indicating their opposite
orientations. Based on the above ﬁndings, compound 3 was identiﬁed
as a new valerian-type ester iridoid glycoside and named as dioscoridin
B.
Compound 4 was isolated as an amorphous powder. The molecular
formula, C33H48O17, was established from the pseudomolecular ion at
m/z 717.2962 ([M+H]+, calcd for C33H49O17, 717.2970) in the po-
sitive ion HRESIMS. Its UV spectrum gave a maximum at 237 nm. The
IR spectrum displayed absorption bands at 3382 (hydroxyl groups),
1702 (ester carbonyls) and 1634 (conjugated C]C) cm−1. Analysis of
1H and 13C-JMOD NMR spectra (Table 2) of 4 revealed its dimeric ir-
idoid structure due to the duplication of the signals typical of an iridoid
glycoside. The signals of the subunits were mostly overlapped except
for the signals of anomeric [δH 4.72 (d, J=8.0 Hz) and 4.67 (d,
J=8.0 Hz)], oleﬁnic (δH 7.49 and 7.41) as well as one oxymethine [δH
4.78 (t, J=9.3 Hz)] protons indicating the structurally resemblance of
the substructures, units “a” and “b”. The 1H NMR spectrum contained
signals due to one oleﬁnic (δH 7.49 s), one hemiacetal (δH 5.23 d,
J=5.6 Hz), two methines (δH 2.90m and 1.75m), two pairs of non-
equivalent methylenes (δH 2.20 and 1.41; 1.88 and 1.20) one methyl
(δH 1.09 d, J=6.2 Hz) as well as an anomeric (δH 4.67 d, J=8.0 Hz)
proton attributed to unit “a”. These signals taken together with the
corresponding 13C resonances which were identiﬁed by the HSQC
spectrum led to the assignment of a deoxyloganic acid [18] as unit “a”
in 4. The remaining resonances in the 1H NMR spectrum particularly
those arising from an oleﬁnic (δH 7.41 s), one hemiacetal (δH 5.25 d,
J=5.6 Hz), two methines (δH 2.90m and 1.75m), two pairs of non-
equivalent methylenes (δH 2.20 and 1.40; 1.88 and 1.20) one methyl
(δH 1.09 d, J=6.2 Hz), one methoxy (δH 3.69 s) as well as an anomeric
(δH 4.72 d, J=8.0 Hz) proton attributed to unit “b” indicated the
second unit to be deoxyloganin [18]. The orientation of the CH3 group
at C-8 in both subunits was established to be β based on the NOE
correlations between H-1 and H-8, between H-9 and H3–10. The at-
tachment site between the deoxyloganin and deoxyloganic acid units
were deduced to be C-11 of unit “a” and C-4′(OH) of unit “b” via an
ester linkage as evidenced from deshielded signal of H-4′ (δH 4.78 t,























































































Fig. 2. Key HMBC (arrow, C→H) and 1H–1H-COSY (bold) correlations of 1–4.
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veriﬁed by the key cross-peak between C-11 (δC 168.5) of unit “a” and
H-4′ of unit “b” in the HMBC spectrum (Fig. 2). Consequently, 4 was
identiﬁed as a new bis-iridoid glycoside and named as dioscoridin C. A
similar bis-iridoid glycoside, picconioside I consisting of deoxyloganic
acid and loganin substructures was reported from Picconia excelca.
However, the ester bond was established between the aglycones of
deoxyloganic acid and loganin moieties (C-11 to C-7) in picconioside I
[19].
The known isolates were identiﬁed by comparison of NMR data with
those reported in the literatures as 8-epi-deoxyloganin aglycone (5)
[20], 10-acetylpatrinoside (6) [21], 10,2′-diacetylpatrinoside (7) [22],
hesperidin [23], caﬀeic acid, chlorogenic acid, 4,5-dicaﬀeoylquinic acid
[24] and β-sitosterol [25].
In this study seven iridoids, including a pyran ring-opened iridoid,
three “Valeriana-type” ester iridoid glycosides and a bis-iridiod glyco-
side were obtained from V. dioscoridis. Iridoids are accepted as che-
motaxonomically useful secondary metabolites particularly in dicoty-
ledonous angiosperm [26]. Further, iridoid composition of some plant
species is utilized to support the phylogenetic studies. The genera Va-
leriana and Patrinia were moved from their traditional family Valer-
ianaceae to their new family Caprifoliaceae based on the phylogenetic
analyses of chloroplast DNA sequences and they were found to be close
to each other [27,28]. “Valeriana-type” ester iridoids, particularly pa-
trinoside derivatives were previously reported from the genus Patrinia
[29] which supports the relationship between Valeriana and Patrinia
within their new family Caprifoliaceae. Furthermore, similar iridoids
were also reported from two genera of Adoxaceae; Sambucus [30–32]
and Viburnum (Adoxaceae) [21,22,33]. The occurrence of such rare
iridoids in these genera implies a chemotaxonomic proximity within
these genera and might be used to support phylogenetic studies in the
future. This study also reports for the ﬁrst time the presence of a di-
meric iridoid glycoside, (dioscoridin C, 4) in the genus Valeriana which
could have a chemotaxonomic potential for the title species.
Iridoids (1–7) were tested for their antiproliferative eﬀects against
three human cancer cell lines (HeLa, A2780 and T47D) at 10 30 and
60 μM concentrations, using the MTT assay (Table 3). All of the tested
compounds elicited modest antiproliferative activity when compared to
reference agent, cisplatin. Concerning the newly isolated molecules, 1-
epi-bosnarol (2) proved to be the most eﬀective exerting inhibition
higher than 50% of cell growth at 60 μM on all used cell lines. 10,2′-
diacetylpatrinoside (7) on the other hand showed similar action at
lower concentration (30 μM) against ovarian and breast cancer cells.
Cervical cell line seems to be less sensitive to the tested iridoids. Several
iridoids isolated from other Valeriana species were evaluated for their in
vitro cytotoxic or antiproliferative activities against some cancer lines in
previous studies [1,8,10]. However, all isolated iridoids in this study
were evaluated for their in vitro antiproliferative activities against
human cancer cell lines for the ﬁrst time.
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